Administration of SARS-CoV-2 DNA plasmid encoding spike protein vaccine

Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (procedure)

procedure

£1.00

Supplier: international · SCTID 1193583000

Also known as (14)

2019 novel coronavirus DNA plasmid encoding spike protein immunisation
2019 novel coronavirus DNA plasmid encoding spike protein immunization
2019 novel coronavirus DNA plasmid encoding spike protein vaccination
2019-nCoV DNA plasmid encoding spike protein immunisation
2019-nCoV DNA plasmid encoding spike protein immunization
2019-nCoV DNA plasmid encoding spike protein vaccination
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein
COVID-19 DNA plasmid encoding spike protein immunisation
COVID-19 DNA plasmid encoding spike protein immunization
COVID-19 DNA plasmid encoding spike protein vaccination
SARS-CoV-2 DNA plasmid encoding spike protein immunisation
SARS-CoV-2 DNA plasmid encoding spike protein immunization
SARS-CoV-2 DNA plasmid encoding spike protein vaccination
Severe acute respiratory syndrome coronavirus 2 DNA plasmid encoding spike protein vaccination